NYSE:KDMN
Delisted
Kadmon Holdings LLC Stock News
$9.50
+0 (+0%)
At Close: Aug 17, 2022
3 Biotech Stocks That Surged in September
07:39am, Tuesday, 05'th Oct 2021
Find out why last month was a big one for these three drugmakers.
Kadmon Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer's 36th Annual Meeting
08:01am, Friday, 01'st Oct 2021
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion pro
SHAREHOLDER ALERT: WeissLaw LLP Reminds CXP, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations
06:20pm, Thursday, 30'th Sep 2021
NEW YORK, Sept. 30, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights
3 Big Drug/Biotech Stocks to Boost Your Portfolio's Health
11:08am, Thursday, 30'th Sep 2021
Sanofi (SNY), Pfizer (PFE) and Novo Nordisk (NVO) are three large drugmakers that are worth betting on in the current scenario.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Kadmon Holdings, Inc. - KDMN
03:17pm, Monday, 13'th Sep 2021
NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class A
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Kadmon Holdings, Inc. (NASDAQ: KDMN) to Sanofi for $9.50 per share in cash is fair
KDMN Stock: Why It Surged Today
08:54pm, Wednesday, 08'th Sep 2021
The stock price of Kadmon Holdings Inc (NASDAQ: KDMN) increased 71.13% today. This is why it The post KDMN Stock: Why It Surged Today appeared first on Pulse 2.0.
Shareholder Alert: Ademi LLP investigates whether Kadmon Holdings, Inc. has obtained a Fair Price in its transaction with Sanofi
12:30pm, Wednesday, 08'th Sep 2021
MILWAUKEE, Sept. 8, 2021 /PRNewswire/ -- Ademi LLP is investigating Kadmon (NASDAQ:KDMN), for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi.
Sanofi (SNY) to Buy Kadmon for $1.9B, Add cGVHD Drug Rezurock
11:00am, Wednesday, 08'th Sep 2021
Sanofi (SNY) offers $1.9 billion to buy Kadmon Holdings to strengthen its transplant business.
Why Kadmon Holdings Stock Is Rocketing Higher Today
08:38am, Wednesday, 08'th Sep 2021
Sanofi adds another bolt-on acquisition in what is turning out to be a busy year for the French pharma titan.
Sanofi to acquire Kadmon to further strengthen growth of transplant business
08:08am, Wednesday, 08'th Sep 2021
Dear recipient,Please note this is a corrected french version of the release which replaces the release sent on September 8 at 8.31 am Paris time where the word « … relutif» has been replaced wit
Kadmon Stock Soars as Sanofi Buys U.S. Biotech for $1.9 Billion
07:54am, Wednesday, 08'th Sep 2021
French drugmaker Sanofi is buying Kadmon, the U.S. biopharmaceutical company, for a total equity value of $1.9 billion.
Sanofi's $1.9 Billion Bet On Kadmon: What You Need to Know
06:30am, Wednesday, 08'th Sep 2021
Underlining the focus on inorganic growth, French pharma giant Sanofi (NASDAQ: SNY) announced a big-ticket acquisition just a month after another billion-dollar deal. Sanofi-Kadmon Deal Terms: Sano
KDMN Stock: Over 75% Stock Increase Pre-Market Explanation
06:04am, Wednesday, 08'th Sep 2021
The stock price of Kadmon Holdings Inc (NASDAQ: KDMN) increased by over 75% pre-market. This is why it happened.